Face Recognition Training for Face Blindness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two new training programs to assist individuals with face blindness, also known as developmental prosopagnosia. The researchers aim to determine if face memory training or face perception training can enhance the ability to recognize and remember faces. Participants will be randomly assigned to one of three groups: memory training, perception training, or a control group. The study seeks individuals who have consistently struggled to recognize faces in everyday situations, unrelated to any specific medical event. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could lead to new methods for improving face recognition.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have ADHD, your medication must have been consistent for the past 6 months. Also, if you are currently in a behavioral or pharmacological intervention, you cannot participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that memory and perception training programs for face blindness are generally easy for people to handle. Previous studies have explored various methods to help individuals with prosopagnosia, or face blindness, improve face processing. These methods often use computer-based training and have not been linked to major side effects.
For face memory training, studies suggest that participants can safely engage in sessions that enhance their ability to remember faces. Similarly, face perception training, which aids in recognizing differences in facial features, has not raised major safety concerns.
Although specific safety data for these exact training programs is limited, both types of training are non-invasive and resemble mental exercises or puzzles. This makes them relatively low-risk compared to other medical treatments. Participants have generally completed these training sessions without significant issues.12345Why are researchers excited about this trial?
Researchers are excited about the face recognition training trial for face blindness because it explores innovative ways to improve facial recognition skills. Unlike traditional therapies that might focus on general cognitive training or compensatory strategies, this trial specifically targets face memory and perception through structured exercises. The face memory training aims to enhance how well individuals can remember faces by gradually increasing the difficulty, while the face perception training hones the ability to discern subtle differences in facial features. This targeted approach could offer more effective and specialized support for people with face blindness, potentially leading to better social interactions and quality of life.
What evidence suggests that this trial's treatments could be effective for face blindness?
Research has shown that face memory training, which participants in this trial may receive, can help individuals with face blindness, also known as developmental prosopagnosia, recognize faces better. In a study by Bate and colleagues, 10 adults with this condition improved their ability to remember faces after completing a face memory training program. This suggests that enhancing face memory can be beneficial.
For face perception training, another treatment option in this trial, results are mixed. Some studies suggest it might improve how people process faces, but many experts believe that significant improvements are difficult to achieve. However, ongoing research is exploring the effectiveness of these training programs, especially when they focus on recognizing specific facial features like the distance between the eyes and eyebrows.12367Who Is on the Research Team?
Joseph DeGutis, Ph.D.
Principal Investigator
Harvard Medical School/VA Boston Healthcare Systems
Are You a Good Fit for This Trial?
This trial is for adults aged 18-90 with lifelong difficulties in recognizing faces, impacting daily life. They must perform poorly on specific face recognition tests. Excluded are those with severe cognitive impairments, psychiatric disorders like schizophrenia or major depression, substance dependence, recent behavioral interventions, or significant neurological disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 6 weeks of face perception or memory training, or active control training
Post-Treatment Assessment
Participants are assessed within two weeks of training completion
Follow-up
Participants are monitored for changes in face recognition abilities after a 12-week no-contact period
What Are the Treatments Tested in This Trial?
Interventions
- Face Memory Training
- Face Perception Training
- Placebo control training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston VA Research Institute, Inc.
Lead Sponsor